Evidence map›Paper›PMID 29604208›Full record

ReviewBiological chemistry2019

The role of the innate immune system on pulmonary infections.

Michelle Galeas-Pena, Nathaniel McLaughlin, Derek Pociask

Open access · bronzeAbstract readReview
In one paragraph

Review in Biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Host-Pathogen Interactions inDiagnostics (Basel, Switzerland) · 2024
    Article
  11. A standardized extract ofPharmaceutical biology · 2023
    Article
  12. Review
  13. In Vitro Antiviral and Anti-Inflammatory Activities ofInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Review
  16. International journal of molecular sciences · 2022
    Article
  17. Host protease activity classifies pneumonia etiology.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  18. Polyphenols-Rich Fraction fromPharmaceutics · 2022
    Article
  19. Effect of environmental pollutants PM2.5, CO, OJournal of King Saud University. Science · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michelle Galeas-PenaDepartment of Pulmonary Critical Care and Environmental Medicine, Tulane University School of Medicine, 333 S. Liberty St., New Orleans, LA 70112, USA.
Nathaniel McLaughlinDepartment of Pulmonary Critical Care and Environmental Medicine, Tulane University School of Medicine, 333 S. Liberty St., New Orleans, LA 70112, USA.
Derek PociaskDepartment of Pulmonary Critical Care and Environmental Medicine, Tulane University School of Medicine, 333 S. Liberty St., New Orleans, LA 70112, USA.
Tulane University · US

Funding

IL-22: A therapeutic cytokine for the amelioration of pulmonary influenza injuryR01HL122760 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI POCIASK, DEREK A · 2015 to 2018
$1.5M
The IL-22/IL-22 binding protein axis is critical for viral induced thymic atrophy and regenerationR21AI117569 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI POCIASK, DEREK A · 2016 to 2017
$414k
NHLBI NIH HHS R01 HL122760NIAID NIH HHS R21 AI117569
6 · The paper itself

Abstract

Inhalation is required for respiration and life in all vertebrates. This process is not without risk, as it potentially exposes the host to environmental pathogens with every breath. This makes the upper respiratory tract one of the most common routes of infection and one of the leading causes of morbidity and mortality in the world. To combat this, the lung relies on the innate immune defenses. In contrast to the adaptive immune system, the innate immune system does not require sensitization, previous exposure or priming to attack foreign particles. In the lung, the innate immune response starts with the epithelial barrier and mucus production and is reinforced by phagocytic cells and T cells. These cells are vital for the production of cytokines, chemokines and anti-microbial peptides that are critical for clearance of infectious agents. In this review, we discuss all aspects of the innate immune response, with a special emphasis on ways to target aspects of the immune response to combat antibiotic resistant bacteria.

Indexed as

AnimalsHumansImmune SystemImmunity, InnateLung DiseaseschemokinecytokineslungmacrophagesT cellsToll like receptors

Identifiers

PMID29604208
PMCPMC9605710
OpenAlexW2894876556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.